High-Dose Benzodiazepine Cohort Addendum Announced Supplementary Files

Written by

in

An addendum about missing supplementary material does not create a new cohort.

What the supplied source reports

The supplied one-page notice states that supplementary files were absent when a nationwide high-dose benzodiazepine cohort article was originally published and had subsequently been made available. It identifies the original study and its five-year follow-up topic.

Limits of the evidence

The notice contains no new participant numbers, dose distributions or risk estimates. Its title cannot substitute for the original methods or supplementary definitions. In particular, it does not independently establish what threshold defined high-dose use or how exposure was modeled.

Implications for expert analysis

For an expert literature inventory, connect the notice to the underlying paper and record the document type. Before asserting a quantitative high-dose finding, use the study text that actually reports it. This notice is a record of added materials, not a second observation supporting the cohort conclusion.

Source and related reading

Source: Publication PMC12724083, read from the supplied PDF. Applications to expert analysis are interpretation.

Related reading: COVID-ARDS Sedation Cohort’s Shorter Stay Was Confounded by Very High Mortality.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *